KMC Speciality Hospitals Provides Corporate Guarantee of Rs. 98.57 Crores for Holding Company's SBI Loan

1 min read     Updated on 11 Feb 2026, 12:11 PM
scanx
Reviewed by
Ashish TScanX News Team
Overview

KMC Speciality Hospitals (India) Limited has provided a corporate guarantee of Rs. 98.57 crores for a State Bank of India loan availed by its holding company Sri Kauvery Medical Care (India) Limited. The guarantee amount represents 60% of the company's tangible net worth as on March 31, 2025, and is within limits approved by shareholders in 2020. The transaction is conducted on arms length basis with no current adverse impact on the company.

32337673

*this image is generated using AI for illustrative purposes only.

KMC Speciality Hospitals (India) Limited has announced the provision of a corporate guarantee worth Rs. 98.57 crores for a loan facility availed by its holding company from State Bank of India. The guarantee represents a significant financial commitment as part of the group's funding arrangements.

Corporate Guarantee Details

The company has provided the corporate guarantee and security for Sri Kauvery Medical Care (India) Limited, which serves as both the holding company and promoter of KMC Speciality Hospitals. The guarantee amount of Rs. 98.57 crores corresponds to 60% of the company's tangible net worth as on March 31, 2025.

Parameter Details
Guarantee Amount Rs. 98.57 crores
Beneficiary Sri Kauvery Medical Care (India) Limited
Lender State Bank of India
Basis 60% of Tangible Net Worth as on March 31, 2025
Transaction Nature Arms length basis

Regulatory Compliance

The corporate guarantee falls within the limits previously approved by shareholders under Section 186 of the Companies Act 2013. This approval was granted during the Annual General Meeting held on September 28, 2020, ensuring compliance with statutory requirements for such financial commitments.

The company has fulfilled its disclosure obligations under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, providing comprehensive details as required by the recent SEBI circular dated January 30, 2026.

Reciprocal Arrangement

As part of the group's financial structure, the holding company Sri Kauvery Medical Care (India) Limited has also provided a corporate guarantee for loans availed by KMC Speciality Hospitals to the extent of Rs. 98.40 crores. This reciprocal arrangement demonstrates the interconnected financial support within the group entities.

Impact Assessment

According to the company's disclosure, there is currently no adverse impact of this guarantee on KMC Speciality Hospitals. The guarantee is provided for the loan availed by its holding company as part of normal business operations and group financial management strategies.

The transaction maintains transparency through proper regulatory filings and adherence to corporate governance standards, with all details provided to the stock exchanges as required under applicable regulations.

Historical Stock Returns for KMC Speciality Hospitals

1 Day5 Days1 Month6 Months1 Year5 Years
+7.49%+16.49%+0.10%+32.24%+17.64%+275.16%
KMC Speciality Hospitals
View Company Insights
View All News
like16
dislike

KMC Speciality Hospitals Reports 82.7% Profit Growth in Q3FY26

2 min read     Updated on 11 Feb 2026, 11:57 AM
scanx
Reviewed by
Jubin VScanX News Team
Overview

KMC Speciality Hospitals (India) Limited reported exceptional Q3FY26 results with net profit surging 82.7% to ₹1,372.78 lakhs and revenue growing 33.7% to ₹8,206.03 lakhs. The nine-month performance was equally impressive with profit increasing 89.9% to ₹3,210.40 lakhs and revenue rising 31.0% to ₹22,351.51 lakhs. The healthcare services provider demonstrated strong operational efficiency with controlled expense growth and improved earnings per share of ₹0.84 for the quarter.

32336874

*this image is generated using AI for illustrative purposes only.

kmc speciality hospitals (India) Limited delivered exceptional financial performance in Q3FY26, demonstrating strong growth across key metrics. The healthcare services provider announced its unaudited financial results for the quarter and nine months ended December 31, 2025, showcasing robust operational efficiency and revenue expansion.

Strong Quarterly Performance

The company's Q3FY26 results reflect significant improvement in profitability and revenue generation. Net profit for the quarter surged to ₹1,372.78 lakhs, representing an impressive 82.7% increase from ₹751.38 lakhs recorded in Q3FY25.

Financial Metric: Q3FY26 Q3FY25 Growth (%)
Revenue from Operations: ₹8,206.03 lakhs ₹6,136.41 lakhs +33.7%
Total Income: ₹8,318.58 lakhs ₹6,257.84 lakhs +32.9%
Profit Before Tax: ₹1,847.52 lakhs ₹1,004.82 lakhs +83.9%
Net Profit: ₹1,372.78 lakhs ₹751.38 lakhs +82.7%
Earnings Per Share: ₹0.84 ₹0.46 +82.6%

Nine-Month Performance Highlights

The company's nine-month performance for FY26 continued the positive trajectory established in the quarterly results. Revenue from operations reached ₹22,351.51 lakhs, marking a substantial 31.0% increase from ₹17,066.28 lakhs in the corresponding nine-month period of FY25.

Parameter: 9M FY26 9M FY25 Change (%)
Revenue from Operations: ₹22,351.51 lakhs ₹17,066.28 lakhs +31.0%
Total Income: ₹22,668.53 lakhs ₹17,295.71 lakhs +31.1%
Net Profit: ₹3,210.40 lakhs ₹1,690.51 lakhs +89.9%
Earnings Per Share: ₹1.97 ₹1.04 +89.4%

Operational Efficiency and Cost Management

The company demonstrated effective cost management while scaling operations. Total expenses for Q3FY26 increased to ₹6,471.06 lakhs from ₹5,253.02 lakhs in Q3FY25, representing a 23.2% rise that was significantly lower than the revenue growth rate. Key expense categories showed controlled growth:

  • Employee benefits expense rose to ₹1,757.12 lakhs from ₹1,356.50 lakhs
  • Finance costs decreased to ₹206.63 lakhs from ₹232.96 lakhs
  • Depreciation and amortisation expense increased to ₹533.95 lakhs from ₹484.95 lakhs

Corporate Governance and Compliance

The Board of Directors approved the unaudited financial results during their meeting held on February 11, 2026, which commenced at 10:30 AM and concluded at 11:25 AM. The results were reviewed by Deloitte Haskins & Sells, the company's statutory auditors, who issued an unmodified review report. The company operates in a single segment of "Medical and Healthcare Services" and maintains compliance with all regulatory requirements under SEBI (LODR) Regulations 2015.

Financial Position and Shareholder Value

KMC Speciality Hospitals maintained a stable capital structure with paid-up equity share capital of ₹1,630.85 lakhs, consisting of shares with a face value of Re. 1 each. The company's strong financial performance translated into enhanced shareholder value, with both basic and diluted earnings per share reaching ₹0.84 for Q3FY26, compared to ₹0.46 in the corresponding quarter of the previous year.

Historical Stock Returns for KMC Speciality Hospitals

1 Day5 Days1 Month6 Months1 Year5 Years
+7.49%+16.49%+0.10%+32.24%+17.64%+275.16%
KMC Speciality Hospitals
View Company Insights
View All News
like19
dislike

More News on KMC Speciality Hospitals

1 Year Returns:+17.64%